Morgan Keegan Reiterates Outperform on Brookdale Senior Living, Reduces PT to $30

Morgan Keegan reiterated its Outperform rating on Brookdale Senior Living BKD. At the same time, the rating agency reduced its price target on the company's stock from $31 to $30. On Tuesday, BKD lost 2.12% of its value to end the day at $19.90.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetReiterationAnalyst RatingsHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!